The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly

N/ACompletedNCT01370577

AstraZeneca297 enrolled

Overview

The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly

Study Type

OBSERVATIONAL

Enrollment

297

Conditions

Asthma

Eligibility

Sex: ALLMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 60 years or more, articulate in Korean * Patients diagnosed with asthma, at least 1 year in duration. Exclusion Criteria: * Patients being followed-up for asthma treatment less than 1 year before baseline * Patients taking immune therapy * Patients previously enrolled/randomized in the present clinical trial

Locations (5)

Research Site

Wŏnju, Gangwon-do, South Korea

Research Site

Anyang-si, Gyeonggi-do, South Korea

Research Site

Suwon, Gyeonggi-do, South Korea

Research Site

Busan, Gyeonsangnam-do, South Korea

Research Site

Outcomes

Primary Outcomes

Baseline characteristics related to asthma control in the elderly

Time frame: 6 months

Asthma exacerbation rate of the elderly during guideline-based stepwise treatments

Time frame: 6 months

Secondary Outcomes

1. Proportion of controlled, partially controlled, and controlled patients among the elderly patients with asthma in Korea

Time frame: 6 months

2. Baseline characteristics related to asthma specific QOL in the elderly patients with asthma

Time frame: 6 months

Mean frequency of PFT, sputum assessments, refill adherence(%), prescription persistence in elderly asthma for the last 1 year before study enrollment

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.